Galera Therapeutics, Inc. (GRTX) — Capital Expenditures
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2024 | $0 | -100.0% |
| 2023 | $59.0K | +136.0% |
| 2022 | $25.0K | -91.2% |
| 2021 | $283.0K | -38.1% |
| 2020 | $457.0K | -27.8% |
| 2019 | $633.0K | +82.4% |
| 2018 | $347.0K | — |
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2024 | $0 | -100.0% |
| 2023 | $59.0K | +136.0% |
| 2022 | $25.0K | -91.2% |
| 2021 | $283.0K | -38.1% |
| 2020 | $457.0K | -27.8% |
| 2019 | $633.0K | +82.4% |
| 2018 | $347.0K | — |